SCHEMBL171656

SCHEMBL171656

N#Cc1cccc(C(O)I)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.46
GSK3B P49841 2/20 0.43
GRM4 Q14833 1/20 0.43
TNF P01375 1/20 0.40
TSHR P16473 2/20 0.39
CLK4 Q9HAZ1 1/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
S1PR1 P21453 2/20 0.38
IDO1 P14902 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ADRA1D P25100 3/20 0.37
ADRA2B P18089 1/20 0.37
ADRA1A P35348 1/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11601220 0.83 ENPP2 (0.48) ENPP2GSK3BGRM4TNFTSHR
SCHEMBL4693798 0.83 ENPP2 (0.48) ENPP2GSK3BGRM4TNFTSHR
SCHEMBL30583447 0.80 ENPP2 (0.46) ENPP2GSK3BGRM4TNFS1PR1
SCHEMBL29857813 0.80 ENPP2 (0.46) ENPP2GSK3BGRM4TNFS1PR1
SCHEMBL27948985 0.80 GSK3B (0.51) ENPP2GSK3BGRM4TNFTSHR
SCHEMBL23056923 0.80 GLA (0.44) ENPP2GSK3BTSHRCLK4S1PR1
SCHEMBL320196 0.80 ENPP2 (0.46) ENPP2GSK3BGRM4TNFS1PR1
SCHEMBL214901 0.80 ENPP2 (0.46) ENPP2GSK3BGRM4TNFS1PR1
SCHEMBL7353228 0.80 TSHR (0.57) ENPP2GSK3BGRM4TNFTSHR
SCHEMBL4095529 0.80 ENPP2 (0.46) ENPP2GSK3BGRM4TNFS1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3184526-A1 PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AS JANUS KINASE INHIBITOR Incyte Holdings Corporation (US) 2017-06-28 EP disclosed
EP-2426129-A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors Incyte Corporation (US) 2012-03-07 EP disclosed